Tag: AACR
Innate Pharma: IPH45 data presented at AACR – 04/10/2024 at 07:42
(CercleFinance.com) – Innate Pharma announces that the first preclinical data relating to IPH45, its exatecan-based antibody-drug conjugate (ADC), were presented at the 2024 annual meeting of the American Association for…
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034
By Alexandra Saintpierre Published on 04/08/2024 at 8:52 p.m. Photo credit © SunocciPictures (Boursier.com) — The biotechnology…
MaaT Pharma presents promising preclinical data at AACR for MaaT034 aimed at improving patient responses to immunotherapies – 04/08/2024 at 7:30 p.m.
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aimed to Improve Patient Responses to Immunotherapies Lyon, France, April 8, 2024, 7:20 p.m. CET – MaaT Pharma (EURONEXT: MAAT…
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050 – 04/08/2022 at 19:00
Transgene will discuss new immunogenicity and clinical data generated with TG4050 that reinforce the strong potential of this individualized immunotherapy:o Relevant neoantigens could be identified in all evaluable patients and…
Transgene presents new preliminary Phase I data confirming the potential of TG4050 at the AACR 2022 congress – 04/08/2022 at 19:00
Transgene presents new clinical and immunogenicity data for TG4050 that confirm the significant potential of this individualized immunotherapy:o In all evaluable patients, target neoantigens could be identified; TG4050 induced specific…